文献速递乳腺技术与安全US

在常规腋窝超声基础上加入超声造影标记可提高预测乳腺癌患者腋窝淋巴结转移的特异性

Adding contrast-enhanced ultrasound markers to conventional axillary ultrasound improves specificity for predicting axillary lymph node metastasis in patients with breast cancer.
PubMed 文献 · Br J Radiol · 2020-12-22

这项回顾性研究纳入259例乳腺癌患者,评估常规腋窝超声与超声造影(CEUS)联合预测腋窝淋巴结转移的诊断效能。常规超声中淋巴结形态和血管模式为独立预测因素,CEUS中最大信号强度、造影增强持续时间和达峰时间为独立预测因素。联合模型AUC为0.965,优于单独CEUS(AUC=0.936)和单独常规超声(AUC=0.851)。

要点

  • 常规超声中淋巴结形态和血管模式是预测腋窝淋巴结转移的独立因素
  • CEUS中最大信号强度、造影增强持续时间和达峰时间是独立预测因素
  • 联合常规超声与CEUS特征AUC=0.965,优于单独任一方法

核心结论

  • 联合常规超声与CEUS特征判别腋窝淋巴结状态的效能优于单独使用CEUS或常规超声特征。

研究设计与样本

  • 回顾性研究,纳入259例乳腺癌患者,均接受常规超声和CEUS检查。
  • 评估常规超声参数包括短轴直径(S)、长轴/短轴比值(L/S)、皮质厚度、阻力指数(RI)、灰度超声淋巴结形态、淋巴门和血管模式。
  • 评估CEUS参数包括增强模式、流入时间、达峰时间(TP)、最大信号强度和造影增强持续时间。

关键影像表现/征象

  • 常规超声中淋巴结形态和血管模式为预测转移性腋窝淋巴结的独立因素。
  • CEUS中最大信号强度、造影增强持续时间和达峰时间为预测转移性腋窝淋巴结的独立因素。

诊断标准与关键数值

  • 联合模型(常规超声+CEUS特征)AUC=0.965。
  • CEUS模型AUC=0.936。
  • 常规超声模型AUC=0.851。

临床应用与阅片要点

  • 将常规超声淋巴结形态与血管模式,以及CEUS的最大信号强度、造影增强持续时间和达峰时间联合用于预测腋窝淋巴结状态,可提高判别特异性。
  • 腋窝淋巴结状态影响乳腺癌治疗决策,联合超声特征有助于治疗计划优化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the diagnostic performance of contrast-enhanced ultrasound (CEUS) combined with conventional ultrasound of axillary lymph nodes (ALNs) in predicting metastatic ALNs in patients with breast cancer.

METHODS: This retrospective study included 259 patients with breast cancer who underwent conventional ultrasound and CEUS. The parameters and patterns evaluated on conventional ultrasound included short axis diameter (S), long axis/short axis (L/S) ratio, cortical thickness, resistive index (RI), lymph node (LN) morphology of greyscale ultrasound, hilum and vascular pattern. Meanwhile, enhancement pattern, wash-in time, time to peak (TP), maximum signal intensity, and duration of contrast enhancement were evaluated on CEUS. Univariate and multiple logistic regression analyses were performed to identify independent factors of ALN status. Three models (conventional ultrasound, CEUS, and combined parameters) were established. Receiver operating characteristic (ROC) curves were applied to evaluate the accuracy of the three predictive models.

RESULTS: On conventional axillary ultrasound, LN morphology and vascular pattern were independent factors in predicting metastatic ALNs. On CEUS, maximum signal intensity, duration of contrast enhancement, and TP were independent factors in predicting metastatic ALNs. When combining conventional ultrasound and CEUS features, five independent factors obtained from the conventional ultrasound and CEUS were associated with ALN status. ROC curve analysis showed that the use of CEUS markers combined with conventional ultrasound features (AUC = 0.965) was superior to the use of CEUS markers (AUC = 0.936) and conventional ultrasound features alone (AUC = 0.851).

CONCLUSION: Combining conventional ultrasound and CEUS features can enable discrimination of ALN status better than the use of CEUS and conventional ultrasound features alone.

ADVANCES IN KNOWLEDGE: The axillary lymph node status in breast cancer patients impacts the treatment decision. Our ultrasonic data demonstrated that CEUS features of ALNs in breast cancer patients could be image markers for predicting ALN status. Combining conventional ultrasound and CEUS features of ALNs can improve specificity discrimination of ALN status better than the use of CEUS and the conventional ultrasound features alone, which will help the treatment planning optimization.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Du LW, Liu HL, Gong HY, et al. Adding contrast-enhanced ultrasound markers to conventional axillary ultrasound improves specificity for predicting axillary lymph node metastasis in patients with breast cancer. Br J Radiol. 2020. PMID: 32976019. doi:10.1259/bjr.20200874

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。